Trial Profile
An Open Label, Fixed-Sequence, Glucose Clamp Study to Compare Molar Potency of HM12470 and Regular Human Insulin in Healthy Subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 08 Nov 2017
Price :
$35
*
At a glance
- Drugs Insulin (Primary)
- Indications Type 1 diabetes mellitus; Type 2 diabetes mellitus
- Focus Therapeutic Use
- Sponsors Hanmi Pharmaceutical
- 08 Nov 2017 New trial record